The oriented development of antituaberculotics: In acyl moiety halogenated 3-(4-alkylphenyl)salicylanilides and corresponding 3-(4-alkylphenyl)benzoxazine-2,4(3H)-diones
The oriented development of antituaberculotics: In acyl moiety halogenated 3-(4-alkylphenyl)salicylanilides and corresponding 3-(4-alkylphenyl)benzoxazine-2,4(3H)-diones